SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Abbott Plans to Separate Global Nutrition Business

Abbott Laboratories said it plans to separate its nutrition business into an independent, publicly traded company.

ABT

Abbott Laboratories (NYSE: ABT) said Wednesday that it intends to make its nutrition business an independent, publicly traded company.